Mutation-driven mechanisms underlying antibiotic resistance of Helicobacter pylori in Asia: A systematic review and meta-analysis (2000-2024)
Abstract
Background: More than half of the global population is infected with Helicobacter pylori (H. pylori). Rising antibiotic resistance has weakened the effectiveness of conventional eradication therapies. We conducted a systematic review and meta-analysis of studies published between 2000 and 2024 across Asia to evaluate the relationship between antibiotic resistance and mutations.
Methods: We did a systematic review and meta-analysis of primary antibiotic resistance to H. pylori and efficacy of first-line regimens in the Asia-Pacific region. Database such as Google Scholar, PubMed, Science Direct, and Web of Science were searched to find research papers published between 2000 and 2024. To evaluate heterogeneity, statistical techniques such as meta-regression, I2 statistics, and Cochran's Q test were used. The data were then combined into forest plots.
Results: Clarithromycin resistance in H. pylori is mainly driven by A2142G/A2143G mutations (19-34%), while metronidazole resistance exceeds 84% in East Asia via rdxA mutations. Amoxicillin resistance (6-34%) links to pbp1A variants, and levofloxacin resistance (31-66%) to gyrA/B mutations. The high heterogeneity highlights the need for standardized diagnostics and region-specific therapies.
Interpretation: According to this study, H. pylori resistance is caused by genetic alterations throughout Asia. Treatments tailored to a certain region and ongoing monitoring are necessary due to rising antibiotic resistance. Regional trends…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.